Correction to: Leukemia; https://doi.org/10.1038/leu.2017.294; published online 17 October 2017
The original version of this Article contained an error in the spelling of the author Juan Carlos Rodriguez-Manzaneque, which was incorrectly given as J Carlos Rodríguez-Manzaneque. This has now been corrected in both the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Prieto, C., López-Millán, B., Roca-Ho, H. et al. Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL. Leukemia 32, 2306 (2018). https://doi.org/10.1038/s41375-018-0236-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-018-0236-4
This article is cited by
-
Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children
Cancer Cell International (2019)
-
Redirecting T cells to treat solid pediatric cancers
Cancer and Metastasis Reviews (2019)